BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36470093)

  • 1. Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study.
    Morfouace M; Horak P; Kreutzfeldt S; Stevovic A; de Rojas T; Denisova E; Hutter B; Bautista F; Oliveira J; Defachelles AS; White J; Kasper B; Preusser M; Golfinopoulos V; Pfister S; Van der Graaf W; Wardelmann E; Shenjere P; Fröhling S; McCabe MG
    Eur J Cancer; 2023 Jan; 178():216-226. PubMed ID: 36470093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EORTC SPECTA-AYA: A unique molecular profiling platform for adolescents and young adults with cancer in Europe.
    de Rojas T; Kasper B; Van der Graaf W; Pfister SM; Bielle F; Ribalta T; Shenjere P; Preusser M; Fröhling S; Golfinopoulos V; Morfouace M; McCabe MG
    Int J Cancer; 2020 Aug; 147(4):1180-1184. PubMed ID: 31465545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.
    Worst BC; van Tilburg CM; Balasubramanian GP; Fiesel P; Witt R; Freitag A; Boudalil M; Previti C; Wolf S; Schmidt S; Chotewutmontri S; Bewerunge-Hudler M; Schick M; Schlesner M; Hutter B; Taylor L; Borst T; Sutter C; Bartram CR; Milde T; Pfaff E; Kulozik AE; von Stackelberg A; Meisel R; Borkhardt A; Reinhardt D; Klusmann JH; Fleischhack G; Tippelt S; Dirksen U; Jürgens H; Kramm CM; von Bueren AO; Westermann F; Fischer M; Burkhardt B; Wößmann W; Nathrath M; Bielack SS; Frühwald MC; Fulda S; Klingebiel T; Koscielniak E; Schwab M; Tremmel R; Driever PH; Schulte JH; Brors B; von Deimling A; Lichter P; Eggert A; Capper D; Pfister SM; Jones DT; Witt O
    Eur J Cancer; 2016 Sep; 65():91-101. PubMed ID: 27479119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
    Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
    Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
    Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
    BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
    Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
    Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high-volume cancer center.
    Bertuzzi AF; Grimaudo MS; Laffi A; Giordano L; Gennaro N; Cariboni U; Siracusano LV; Quagliuolo V; Colombo P; Federico D; Renne SL; Specchia C; Cananzi F; Marrari A; Navarria P; Daolio PA; Bastoni S; Santoro A
    Cancer Med; 2023 Aug; 12(15):16254-16263. PubMed ID: 37366268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers.
    Khater F; Vairy S; Langlois S; Dumoucel S; Sontag T; St-Onge P; Bittencourt H; Dal Soglio D; Champagne J; Duval M; Leclerc JM; Laverdiere C; Tran TH; Patey N; Ellezam B; Perreault S; Piché N; Samson Y; Teira P; Jabado N; Michon B; Brossard J; Marzouki M; Cellot S; Sinnett D
    JAMA Netw Open; 2019 Apr; 2(4):e192906. PubMed ID: 31026031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas.
    Lazow MA; Salloum R; Pressey JG
    J Adolesc Young Adult Oncol; 2023 Apr; 12(2):215-223. PubMed ID: 35675692
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial.
    Italiano A; Dinart D; Soubeyran I; Bellera C; Espérou H; Delmas C; Mercier N; Albert S; Poignie L; Boland A; Bourdon A; Geneste D; Cavaille Q; Laizet Y; Khalifa E; Auzanneau C; Squiban B; Truffaux N; Olaso R; Gerber Z; Wallet C; Bénard A; Blay JY; Laurent-Puig P; Deleuze JF; Lucchesi C; Mathoulin-Pelissier S;
    BMC Cancer; 2021 Nov; 21(1):1180. PubMed ID: 34740331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutational comparison of adult and adolescent and young adult (AYA) colon cancer.
    Tricoli JV; Boardman LA; Patidar R; Sindiri S; Jang JS; Walsh WD; McGregor PM; Camalier CE; Mehaffey MG; Furman WL; Bahrami A; Williams PM; Lih CJ; Conley BA; Khan J
    Cancer; 2018 Mar; 124(5):1070-1082. PubMed ID: 29194591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
    Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
    BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical utility of next-generation sequencing for bone and soft tissue sarcoma.
    Gusho CA; Weiss MC; Lee L; Gitelis S; Blank AT; Wang D; Batus M
    Acta Oncol; 2022 Jan; 61(1):38-44. PubMed ID: 34686105
    [No Abstract]   [Full Text] [Related]  

  • 15. A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
    Spunt SL; Million L; Chi YY; Anderson J; Tian J; Hibbitts E; Coffin C; McCarville MB; Randall RL; Parham DM; Black JO; Kao SC; Hayes-Jordan A; Wolden S; Laurie F; Speights R; Kawashima E; Skapek SX; Meyer W; Pappo AS; Hawkins DS
    Lancet Oncol; 2020 Jan; 21(1):145-161. PubMed ID: 31786124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study.
    Pfaff E; Kessler T; Balasubramanian GP; Berberich A; Schrimpf D; Wick A; Debus J; Unterberg A; Bendszus M; Herold-Mende C; Capper D; Schenkel I; Eisenmenger A; Dettmer S; Brors B; Platten M; Pfister SM; von Deimling A; Jones DTW; Wick W; Sahm F
    Neuro Oncol; 2018 May; 20(6):826-837. PubMed ID: 29165638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
    Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
    J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is There Value in Molecular Profiling of Soft-Tissue Sarcoma?
    Italiano A
    Curr Treat Options Oncol; 2018 Dec; 19(12):78. PubMed ID: 30523434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.